Immune therapies may fight cancer

First there was surgery, then chemotherapy and radiation. Now, doctors have overcome 30 years of false starts and found success with a fourth way to fight cancer: using the body’s natural defender, the immune system.

ORLANDO, Fla. — First there was surgery, then chemotherapy and radiation. Now, doctors have overcome 30 years of false starts and found success with a fourth way to fight cancer: using the body’s natural defender, the immune system.

The approach is called a cancer vaccine, although it treats the disease rather than prevents it.

At a recent cancer conference, researchers said one such vaccine kept a common form of lymphoma from worsening for more than a year. That’s huge in this field, where progress is glacial and success with a new treatment is often measured in weeks or even days.

Experimental vaccines against three other cancers — prostate, the deadly skin disease melanoma and an often fatal childhood tumour called neuroblastoma — also gave positive results in late-stage testing in recent weeks, after decades of struggles in the lab.

“I don’t know what we did differently to make the breakthrough,” said Dr. Len Lichtenfeld of the American Cancer Society.

Instead of a single “A-Ha!” moment, there have been many “ah, so” discoveries about the immune system that now seem to be paying off, said Dr. John Niederhuber, director of the National Cancer Institute. It’s way too soon to declare victory. No one knows how long the benefits will last, whether people will need “boosters” to keep their disease in check, or whether vaccines will ever be a cure. Many vaccines must be custom-made for each patient. How practical will that be, and what will it cost?

Those are all good questions — but there are no answers yet, said Dr. Richard Schilsky, a University of Chicago cancer specialist who is president of the American Society of Clinical Oncology.

Several vaccine studies were reported over the weekend at the oncology group’s annual meeting in Florida.

A big problem has been getting the immune system to “see” cancer as a threat, said Dr. Patrick Hwu, melanoma chief at the University of Texas M.D. Anderson Cancer Center. Viruses like the flu or polio are easily spotted by the immune system because they look different from human cells.

“But cancer comes from our own cells. And so it’s more like guerrilla warfare — the immune system has trouble distinguishing the normal cells from the cancer cells,” he said.

To help it do that, many cancer vaccines take a substance from a cancer cell’s surface and attach it to something the immune system already recognizes as foreign — in the lymphoma vaccine’s case, a shellfish protein.

“It’s a mimic to what you’re trying to kill, a training device to train the immune system to kill something,” Hwu explained.

To make the attack as strong as possible, doctors add a substance to put the immune system on high alert.

Dr. Stephen Schuster of the University of Pennsylvania School of Medicine led a study testing BiovaxID, an experimental vaccine against follicular lymphoma developed by the National Cancer Institute. Rights to it are now held by Biovest International Inc. of Worcester, Mass., and some of his co-researchers have financial ties to the company.

To be in the study, patients had to have achieved a remission for at least six months with standard chemo. This often occurs with this type of lymphoma, but the disease usually comes back.

Researchers gave 41 patients the shellfish protein and an immune booster; 76 other patients were given those plus the vaccine. After nearly five years of followup, the average time until the cancer worsened was 44 months in the vaccine group and 30 months in the others.

Big gains also were seen with a neuroblastoma vaccine developed by the cancer institute. In a study of 226 patients, 86 per cent of vaccine recipients were still alive after two years versus 75 per cent of others not given the vaccine. Results were released by the oncology society two weeks ago.

The benefits from a melanoma vaccine developed by the cancer institute were more modest. It extended the time until patients relapsed — three months versus one and a half for those not given the vaccine.

Hilde Stapleton, 53, of suburban Houston, is one of the lucky ones it helped. Still, she found what many other vaccine recipients have learned: The vaccine had few side effects, but the immune system boosters were “like the worst case of flu you’ve ever had,” she said.

The prostate cancer vaccine, Provenge, is farthest along. Its maker, Seattle-based Dendreon Corp., is seeking federal Food and Drug Administration approval for it. A study last month found that it extended survival by four months in men with very advanced disease.

Doctors unconnected with these experiments are cautiously optimistic.

Just Posted

RCMP looking for these two suspects
Police looking for suspects who stole truck in central Alberta

A Ford F350 was stolen out of Blackfalds on June 9. Two… Continue reading

An excavator is tearing up old parking lots at the Michener Centre north site. (Photo by LANA MICHELIN/Advocate staff).
Demolition gets underway at Michener Centre’s north site

Some people are nostaligic, but not everyone is sad to see it go

The Red Deer Indian Industrial school stood off Burnt Lake Trail and across the Red Deer River from Fort Normandeau. The residential school is known to have lost at least 70 students through illness, poor sanitation and nutrition. (Advocate file photo)
Some Indigenous leaders say SNC-Lavalin can’t make up to First Nations people with offer of help

Quebec company is connected to MP Jody Wilson-Raybould allegations

RCMP are looking for this 30-year-old missing woman.
Red Deer RCMP looking for missing woman

The Red Deer RCMP are asking for the public’s assistance to locate… Continue reading

Canadian Prime Minister Justin Trudeau participates in a plenary session at the G7 Summit in Carbis Bay, England on Friday June 11, 2021. THE CANADIAN PRESS/Adrian Wyld
Canada donating 13M surplus COVID-19 vaccine doses to poor countries

Trudeau says the government will pay for 87 million shots to be distributed to poor countries

(Photo contributed)
Red Deer’s Ernco Braves go 4-0 in opening weekend games

Braves shot out Edmonton Padres in four straight games

Love it or hate it, tequila conjures up strong feelings in many drinkers. For some, there are bad memories. But today’s premium tequilas are changing some of those perceptions. (Photo by The Associated Press)
Rethinking tequila: Premium brands aim to change perceptions

LONDON — Love it or hate it, tequila conjures up strong feelings… Continue reading

This image provided by Glenorangie shows Glenorangie's Giraffe Tin. To enjoy the occasional beverage and also help wildlife, consider Glenorangie's Giraffe Tin. The Highland Scotch maker's stills are the tallest in Scotland, as tall as a giraffe, and the collectible tin is patterned like the animal's coat. Each purchase supports the Giraffe Conservation Foundation. (Glenorangie via AP)
Father’s Day gifts that celebrate interests old and new

After a pandemic year in which the shape of work and play… Continue reading

Pumpjacks are shown pumping crude oil near Halkirk, Alta., on June 20, 2007.  THE CANADIAN PRESS/Larry MacDougal
Canada’s crude oil exports have increased 15-fold in 30 years: report

HALIFAX — The value of crude oil exports from Canada has increased… Continue reading

Everlasting Wind, aka Dawn Goodwin, joins others by raising her fist in the Mississippi River near an Enbridge pipeline construction site, on Monday, June 7, 2021, in Clearwater County, Minn., to protest the construction of Enbridge Line 3. Goodwin is a co-founder of RISE Coalition. More than 2,000 Indigenous leaders and "water protectors" gathered in Clearwater County from around the country. The day started with a prayer circle and moved on to a march to the Mississippi headwaters where the oil pipeline is proposed to be built. (Alex Kormann/Star Tribune via AP)
Minnesota court affirms approval of Line 3 oil pipeline

ST. PAUL, Minn. — The Minnesota Court of Appeals on Monday affirmed… Continue reading

Perrin Beatty, President and CEO of the Canadian Chamber of Commerce, speaks during a news conference held by the Canadian Travel and Tourism Roundtable, a coalition of airports, airlines, hotels, boards of trade and chambers of commerce, to urge the federal government to implement a reopening plan for travel and tourism, at the Ottawa Airport in Ottawa, on Monday, June 14, 2021. THE CANADIAN PRESS/Justin Tang
Canadian business leaders demand plan to reopen borders, economy now

OTTAWA — Business leaders are calling on Ottawa to immediately lay out… Continue reading

The Kamloops Indian Residential School is photographed using a drone in Kamloops, B.C., Monday, June, 14, 2021.  The remains of 215 children were discovered buried near the former school earlier this month. THE CANADIAN PRESS/Jonathan Hayward
Communities grapple with what to do with former residential and day schools

The national spotlight on residential schools is also highlighting a difficult question… Continue reading

Deputy Prime Minister, not shown, and Minister of Finance Chrystia Freeland joins Prime Minister Justin Trudeau as they participate in a virtual discussion from Ottawa on Monday, May 3, 2021. THE CANADIAN PRESS/Sean Kilpatrick
Liberals move to cut debate, force vote on bill to implement 2021 budget

OTTAWA — The Trudeau Liberals moved on Monday to force an end… Continue reading

Most Read